BHVNBiohaven Ltd.

$1B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$199M

Net Income

-$211M

EPS (Diluted)

$-4.67

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$491M

Total Liabilities

$304M

Stockholders' Equity

$187M

Cash & Equivalents

$466M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$199M	-$38M	-422.6%
Net Income	-$211M	-$39M	-437.5%

BHVN Q2 2019 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena